Compare IRAB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRAB | RNAC |
|---|---|---|
| Founded | 2025 | 2007 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.3M | 218.4M |
| IPO Year | 2025 | 2016 |
| Metric | IRAB | RNAC |
|---|---|---|
| Price | $10.05 | $6.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | 54.3K | ★ 123.9K |
| Earning Date | N/A | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $274.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.82 | $5.60 |
| 52 Week High | $10.17 | $11.00 |
| Indicator | IRAB | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 41.34 |
| Support Level | $9.99 | $5.87 |
| Resistance Level | $10.07 | $7.64 |
| Average True Range (ATR) | 0.01 | 0.52 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 43.80 | 12.35 |
Iris Acquisition Corp II is a blank check company.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.